What is the Impact Factor of Signal Transduction and Targeted Therapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Signal Transduction and Targeted Therapy is 81.2, ranking in quartile Q1 of Web of Science (SCIE).

Is Signal Transduction and Targeted Therapy indexed in Web of Science or Scopus?

Yes, Signal Transduction and Targeted Therapy is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 17.7 (Q1) and an H-index of 224.

Who publishes Signal Transduction and Targeted Therapy and what is the Article Processing Charge (APC)?

Signal Transduction and Targeted Therapy is published by Springer Nature. The estimated Article Processing Charge (APC) is approximately $5,098 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Signal Transduction and Targeted Therapy?

The official ISO-4 abbreviation of Signal Transduction and Targeted Therapy is "SIGNAL TRANSDUCTION TARGETED THER" with common acronym "sigtrans". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #25Top JournalGold OA

Signal Transduction and Targeted Therapy

Acronym:sigtrans

•

Abbreviation (ISO):SIGNAL TRANSDUCTION TARGETED THER

•

Identifier (ISSN):2095-9907(Print)/2059-3635(Online)

•

Publisher:Springer Nature

Official Website Submission Portal Compare

Clarivate IF (2026)

81.2↑ +28.5

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Signal Transduction and Targeted Therapy

WoS Q1

Annual Impact Factor Metric

Current (2026):81.2

Scopus SJR & RankScopus Q1

17.74

#25

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

224

224 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate1.2%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

218articles/year

100% Gold OA•60.48% Original Research

Aims & Scope

Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.

Topics Covered (Recognized by AI)

BiologyMedicineGeneticsInternal MedicineChemistryBiochemistryImmunologyPathologyCancer ResearchCell BiologyOncology & Cancer ResearchComputational BiologyPathology & DiseasesVirologyImmune System

Primary Research Areas

Biochemistry Genetics and Molecular Biology Genetics

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Rank1/328

IndexSCIE

JCRSCIE2026

CELL BIOLOGY

Rank2/207

IndexSCIE

JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Rank3/328

IndexSCIE

JCISCIE2026

CELL BIOLOGY

Rank5/207

IndexSCIE

Category	Index	Rank	Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY	JCRSCIE	1/328	Q1
CELL BIOLOGY	JCRSCIE	2/207	Q1
BIOCHEMISTRY & MOLECULAR BIOLOGY	JCISCIE	3/328	Q1
CELL BIOLOGY	JCISCIE	5/207	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

11 year

2026Latest

IF81.2

Articles / Year412

Total Citations1,318

2025

IF52.7

Articles / Year428

Total Citations17,440

2024

IF40.8

Articles / Year370

Total Citations41,712

2023

IF39.3

Articles / Year469

Total Citations64,959

2022

IF38.104

Articles / Year403

Total Citations59,342

Year	Impact Factor	Articles / Year	Total Citations
2026	81.2	412	1,318
2025	52.7	428	17,440
2024	40.8	370	41,712
2023	39.3	469	64,959
2022	38.104	403	59,342
2021	18.187	443	64,731
2020	13.493	301	52,804
2019	5.873	65	8,905
2018	0	33	5,950
2017	—	38	11,566
2016	—	22	3,516

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #25Scopus Q1SCImago Profile

Scopus Coverage:2016-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular Biology

Scopus Citation Rank (SJR)Q1

17.74

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

51.26

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$5,098 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations58,350

3-Year Documents1,207

Citable Documents843

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate41.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1

GeneticsQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 1.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区BIOCHEMISTRY & MOLECULAR BIOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Signal Transduction and Targeted Therapy (acronym: sigtrans, abbr: SIGNAL TRANSDUCTION TARGETED THER, ISSN: 2095-9907) is a peer-reviewed international scholarly journal in the field of Biochemistry, published by Springer Nature in United Kingdom since 2016. The periodical holds a Journal Impact Factor (JIF) of 81.2, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 17.7 (Q1), an H-index of 224.

The journal enforces rigorous peer evaluation with an annual output of approximately 218 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $5,098 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.